Anti-BCMA heavy chain-only antibodies
Abstract:
Anti-BCMA heavy chain-only antibodies (HCAb) and disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B-cell disorders characterized by the expression of BCMA.
Public/Granted literature
Information query
Patent Agency Ranking
0/0